tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Richard Vosser, 40 are a BUY (42.55%), 36 are a HOLD (38.3%), 18 are a SELL (19.15%).
Analyst Richard Vosser, currently employed at JPMORGAN, carries an average stock price target met ratio of 45.15% that have a potential upside of 21.36% achieved within 285 days. Previously, Richard Vosser worked at MORGAN STANLEY.
Richard Vosser’s has documented 163 price targets and ratings displayed on 11 stocks. The coverage is on Healthcare, Consumer Cyclical sectors.
Most recent stock forecast was given on NVO, Novo Nordisk A/S at 24-Feb-2026.
Analyst best performing recommendations are on RH (RH).
The best stock recommendation documented was for RH (RH) at 1/3/2023. The price target of $294.29 was fulfilled within 6 days with a profit of $41.01 (16.19%) receiving and performance score of 26.99.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 29-Sep-2025
$40
$2.68 (7.18%)
$47
23 days ago
(11-Sep-2026)
2/2 (100%)
$-3.07 (-7.13%)
23
Hold Since 14-May-2025
$47
$9.68 (25.94%)
$46
1 months 20 days ago
(14-Aug-2026)
9/19 (47.37%)
$1.69 (3.73%)
29
Buy Since 10-Dec-2025
$62
3 months 14 days ago
(20-Jun-2026)
3/4 (75%)
$15.28 (32.71%)
78
Buy Since 19-Jul-2024
$41
$-7.07 (-14.71%)
$54
7 months 2 days ago
(02-Mar-2026)
2/3 (66.67%)
$3.24 (8.58%)
46
Buy Since 07-Jun-2022
7 months 10 days ago
(24-Feb-2026)
10/10 (100%)
$32.06 (35.10%)
255
What Year was the first public recommendation made by Richard Vosser?
